{"pmid":32265531,"title":"COVID-19 and cancer: what we know so far.","text":["COVID-19 and cancer: what we know so far.","Nat Rev Clin Oncol","Sidaway, Peter","32265531"],"journal":"Nat Rev Clin Oncol","authors":["Sidaway, Peter"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265531","week":"202015|Apr 06 - Apr 12","doi":"10.1038/s41571-020-0366-2","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1663609715792281602,"score":7.9164424,"similar":[{"pmid":32273490,"title":"Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","text":["Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic.","Indian Pediatr","Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V","32273490"],"abstract":["Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic."],"journal":"Indian Pediatr","authors":["Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273490","week":"202015|Apr 06 - Apr 12","source":"PubMed","topics":["Treatment","Diagnosis","Mechanism","Transmission"],"weight":1,"_version_":1663712077842219008,"score":67.93228},{"pmid":32139372,"pmcid":"PMC7081812","title":"What we know so far: COVID-19 current clinical knowledge and research.","text":["What we know so far: COVID-19 current clinical knowledge and research.","In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.","Clin Med (Lond)","Lake, Mary A","32139372"],"abstract":["In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features."],"journal":"Clin Med (Lond)","authors":["Lake, Mary A"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32139372","week":"202010|Mar 02 - Mar 08","doi":"10.7861/clinmed.2019-coron","keywords":["*2019-nCoV","*SARS-CoV-2","*Wuhan","*coronavirus","*respiratory tract infection"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Transmission","Prevention"],"weight":1,"_version_":1663352134203080705,"score":65.00456},{"pmid":32245083,"title":"SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","text":["SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.","Pathogens","Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D","32245083"],"abstract":["In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes."],"journal":"Pathogens","authors":["Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245083","week":"202014|Mar 30 - Apr 05","doi":"10.3390/pathogens9030231","keywords":["COVID-19","Coronavirus","SARS","SARS-CoV-2","Wuhan","pandemic"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment","Diagnosis"],"weight":1,"_version_":1663352135817887744,"score":64.59504},{"pmid":32266753,"title":"Intrauterine vertical transmission of SARS-CoV-2: what we know so far.","text":["Intrauterine vertical transmission of SARS-CoV-2: what we know so far.","Ultrasound Obstet Gynecol","Wang, Chen","Zhou, Yi-Hua","Yang, Hui-Xia","Poon, Liona C","32266753"],"journal":"Ultrasound Obstet Gynecol","authors":["Wang, Chen","Zhou, Yi-Hua","Yang, Hui-Xia","Poon, Liona C"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266753","week":"202015|Apr 06 - Apr 12","doi":"10.1002/uog.22045","keywords":["COVID-19","SARS-CoV-2","congenital infection","intrauterine infection","vertical transmission"],"source":"PubMed","topics":["Transmission","Diagnosis"],"weight":1,"_version_":1663609715838418945,"score":64.59504},{"pmid":31980434,"title":"China coronavirus: what do we know so far?","text":["China coronavirus: what do we know so far?","BMJ","Mahase, Elisabeth","31980434"],"journal":"BMJ","authors":["Mahase, Elisabeth"],"date":"2020-01-26T11:00:00Z","year":2020,"_id":"31980434","week":"20204|Jan 20 - Jan 26","doi":"10.1136/bmj.m308","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1663352134872072192,"score":63.0396}]}